Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Generation and characterisation of a PARP-1-deficient heart endothelial cell line

A. Carrillo, Y. Monreal, L. Marin, P. Ramirez, P. Parrilla, J. Yelamos

Med Sci Monit 2003; 9(1): 8-0 :: ID: 15054


Poly(ADP-ribose) polymerase-1 (PARP-1) has been involved in endothelial cell dysfunction associated to various pathophysiological conditions such as reperfusion [1], endotoxic shock [2], diabetes [3] and aging [4]. The intrinsic mechanism of PARP-1-mediated endothelial cell dysfunction might be related to PARP-1 overactivation and ATP depletion. An alternative way in which PARP-1 may influence endothelial cell function could involved transcription regulation [5]. Primary endothelial cells have a limit life span in culture. After 5-6 passages, they tend to de-differentiate and eventually reach senescence which limits their use in studies of endothelial cell function. The aim of this work was to establish an immortalized PARP-1-deficient endothelial cell line. Primary murine heart endothelial cells (MHEC) were isolated from PARP-1 knockout mice [6] (kindly provided by Dr. de Murcia) by collagenase treatment and cell sorting of ICAM-2-positive cells. MHEC were transfected with the pRNS-1 plasmid encoding the SV40 genome (kindly provided by Dr. Ozer) and a clone was selected on the basis of their morphological and phenotypical features. Flow cytometry analysis of this cell line (HYKO6) demonstrated constitutive expression of MHC-Class I, CD105, ICAM-2, and VCAM-1 antigens. Moreover, the HYKO6 cell line was able to up-regulate the expression of E-selectin in response to TNF-a. This cell line has been maintained in culture for many passages without signs of senescence and with preserved characteristics of primary endothelial cells. The HYKO6 cell line will provide a useful tool to study the role played by PARP-1 in endothelial cell dysfunction.References: 1.Szabó C et al: Cir Res, 2002; 90: 100-106 2.Szabó C et al: J Clin Invest, 1997; 100: 723-735 3.García Soriano F et al: Nat Med, 2001; 7: 108-113 4.Pacer P et al: Br J Pharmacol, 2002; 135: 1347-1350 5.Chiarugi A: Trends Pharmacol Sci, 2002; 23: 122-129 6.Menissier de Murcia J et al: Proc Natl Acad Sci USA, 1997; 94: 7303-7307

Keywords: PARP-1, Endothelium, Cell Line

Add Comment 0 Comments

343 0


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750